A multicentre, retrospective comparative study of Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy
Latest Information Update: 18 Jun 2019
At a glance
- Drugs Verteporfin (Primary)
- Indications Central serous chorioretinopathy
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 18 Jun 2019 New trial record